Investor Alert

Market Pulse Archives

Oct. 14, 2021, 7:22 a.m. EDT

Walgreens profit and sales beat expectations

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Walgreens Boots Alliance Inc. (WBA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tonya Garcia

Walgreens Boots Alliance Inc. /zigman2/quotes/203410933/composite WBA -1.54% shares rose 2.5% in Thursday premarket trading after the pharmacy retailer reported fiscal fourth-quarter earnings and sales that beat expectations. Net income totaled $627 million, or 72 cents per share, up from $373 million, or 43 cents per share, last year. Adjusted EPS of $1.17 beat the FactSet consensus for $1.02. Sales of $34.26 billion rose from $30.37 billion and were also ahead of the FactSet consensus for $33.03 billion. U.S. comparable pharmacy sales rose 8.1% while Boots UK comparable pharmacy sales were up 11.4%. U.S. comparable retail sales increased 8.9% while Boots UK comparable retail sales rose 15%. Walgreens provided 13.5 million COVID-19 vaccinations in the quarter, and 34.6 million for the entire fiscal year. Walgreens has a virtual investor conference taking place on Thursday. Walgreens stock has gained 18.5% for the year to date, outpacing the S&P 500 index /zigman2/quotes/210599714/realtime SPX -2.27% , which is up 16.2% for the period.

US : U.S.: Nasdaq
$ 45.90
-0.72 -1.54%
Volume: 5.80M
Nov. 26, 2021 1:00p
P/E Ratio
Dividend Yield
Market Cap
$40.35 billion
Rev. per Employee
-106.84 -2.27%
Volume: 2.10B
Nov. 26, 2021 2:12p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.